EFFECT OF BENZEDRINE SULPHATE ALTERNATED WITH SODIUM AMYTAL IN SCHIZOPHRENIA
Abstract
1. Administration of benzedrine sulphate and sodium amytal on alternating days cannot be recommended as a therapeutic procedure for schizophrenia.
2. While the author is not enthusiastic about results obtainable with metrazol shock therapy in schizophrenia because of the definitely temporary nature of improvement when it does occur, and the serious complications, the results obtained from the trial with benzedrine and amytal, when compared with metrazol shock, were not only considerably inferior but practically negligible.
3. Intravenous injections of large doses of benzedrine sulphate (30 mg.) every other day for a month to young, physically healthy adults caused no harmful effects of permanent nature.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
